Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Neoplasia).php on line 2
Liver (Neoplasia)
LE WE PMID CA
Liver (Neoplasia)1558Leber (Neubildung)

Biliary system (Neoplasia)

Chromophobe hepatocellular carcinoma with abrupt anaplasia

Genetics (Microsatellite)

Glomus tumor

Glypican

Hepatic epithelioid haemangioendothelioma

Hepatic solitary fibrous tumor

Hepatitis B

Hepatitis C

IGF1

Infantile hepatic hemangioendothelioma

Inflammatory myofibroblastic tumor

Inflammatory pseudo tumor of the liver

Inflammatory pseudotumor

Intestines (Malformation)

Liver (Biopsy)

Liver (Cirrhosis)

Liver (Focal nodular hyperplasia)

Liver (Metastasis)

Liver (MRT)

Liver (Neoplasia)

Liver (Sonography)

Liver (Transplantation)

Mesothelin

Neoplasia (Carcinogenesis)

Neoplasia (Radiofrequency ablation)

Nested stromal epithelial tumour of the liver

Neuroendocrine System (Neoplasia Carcinoid)

Neuroendocrine system (Neoplasia)

Pancreas (Neoplasia)

Solitary fibrous tumor of the liver

Trans arterial chemoembolization

Ultrasound (Toxicity and therapeutic use)

1998  
1
Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis.
[9610609] J Korean Med Sci 13(2): 103-16 (1998)
2008  
2
Therapeutical concepts and results for Klatskin tumors.
[19633782] Dtsch Arztebl Int 105(9): 156-61 (2008)
2008  
3
Evolving therapies in the treatment of hepatocellular carcinoma.
[19707376] Biologics 2(3): 453-62 (2008)
2007  
4
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
[17767898] Health Technol Assess 11(34): 1-206 (2007)
2008  
5
Sorafenib, a systemic therapy for hepatocellular carcinoma.
[18376365] Ann Hepatol 7(1): 46-51 (2008)
2006  
6
Focal nodular hyperplasia and hepatic adenoma: a review.
[17060885] Ann Hepatol 5(3): 206-11 (2006)
2006  
7
Hepatocellular carcinoma. An overview.
[16531960] Ann Hepatol 5(1): 16-24 (2006)
2007  
8
Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.
[20485626] Gut Liver 1(2): 101-17 (2007)
2008  
9
A case of primary small cell carcinoma of the liver that was treated with chemotherapy.
[19669327] Hepatol Int 2(4): 500-4 (2008)
2008  
10
Hepatocellular adenoma: what is new in 2008.
[19669260] Hepatol Int 2(3): 316-21 (2008)
1996  
11
Hepatobiliary cystadenomas and cystadenocarcinoma. Report of five cases.
[8871248] HPB Surg 9(2): 83-92 (1996)
1989  
12
1988  
13
Fibrolamellar carcinoma of the liver--a case report from Japan and a review of the literature.
[2856433] HPB Surg 1(1): 77-80 (1988)
2006  
14
Radiofrequency ablation of liver tumors: a systematic review.
[16490897] Arch Surg 141(2): 181-90 (2006)
2006  
15
Spontaneous rupture of hepatocellular carcinoma: a systematic review.
[16490898] Arch Surg 141(2): 191-8 (2006)
2004  
16
Hepatic resection and transplantation for primary carcinoid tumors of the liver.
[14745329] Ann Surg 239(2): 210-9 (2004)
2000  
17
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
[10862190] Ann Surg 232(1): 10-24 (2000)
2000  
18
Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature.
[10636105] Ann Surg 231(1): 74-81 (2000)
1994  
19
Current treatment modalities for hepatocellular carcinoma.
[8147605] Ann Surg 219(3): 236-47 (1994)
1987  
20
Cavernous hemangioma of the liver. A single institution report of 16 resections.
[3555360] Ann Surg 205(5): 456-65 (1987)
1985  
21
Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor.
[2409935] Ann Surg 202(1): 36-41 (1985)
2007  
22
Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.
[17635374] Aliment Pharmacol Ther 26(3): 393-400 (2007)
2006  
23
Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.
[16696801] Aliment Pharmacol Ther 23(11): 1535-47 (2006)
2006  
24
Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection.
[16629938] Aliment Pharmacol Ther 23(9): 1329-35 (2006)
2003  
25
Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma.
[12755838] Aliment Pharmacol Ther 17(10): 1247-61 (2003)
2002  
26
Non-surgical treatment of hepatocellular carcinoma.
[11856073] Aliment Pharmacol Ther 16(1): 1-15 (2002)
1998  
27
Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?
[9692685] Aliment Pharmacol Ther 12(2): 111-26 (1998)
2010  
28
Review article: the management of hepatocellular carcinoma.
[19925500] Aliment Pharmacol Ther 31(4): 461-76 (2010)
2009  
29
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
[19392863] Aliment Pharmacol Ther 30(1): 37-47 (2009)
2008  
30
Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents.
[18808443] Aliment Pharmacol Ther 28(11-12): 1269-77 (2008)
2008  
31
Review article: the evaluation of solitary liver masses.
[18643922] Aliment Pharmacol Ther 28(8): 953-65 (2008)
2003  
32
Review article: liver transplantation for HCC. Treatment options on the waiting list.
[12786626] Aliment Pharmacol Ther 17 Suppl 2(-): 145-50 (2003)
2003  
33
Review article: liver transplantation for hepatocellular carcinoma.
[12786625] Aliment Pharmacol Ther 17 Suppl 2(-): 138-44 (2003)
2003  
34
Review article: hepatocellular carcinoma: indications for liver transplantation.
[12786624] Aliment Pharmacol Ther 17 Suppl 2(-): 130-7 (2003)
2003  
35
Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre.
[12786623] Aliment Pharmacol Ther 17 Suppl 2(-): 119-29 (2003)
2003  
36
Review article: intra-arterial treatments in patients with hepatocellular carcinoma.
[12786622] Aliment Pharmacol Ther 17 Suppl 2(-): 111-8 (2003)
2003  
37
Review article: percutaneous treatment of hepatocellular carcinoma.
[12786621] Aliment Pharmacol Ther 17 Suppl 2(-): 103-10 (2003)
2003  
38
Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma.
[12786620] Aliment Pharmacol Ther 17 Suppl 2(-): 98-102 (2003)
2003  
39
Review article: diagnosis and treatment of Helicobacter: a 2002 updated review.
[12786619] Aliment Pharmacol Ther 17 Suppl 2(-): 89-97 (2003)
2009  
40
Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study.
[19171074] BMC Cancer 9(-): 33 (2009)
2008  
41
Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456757] Ann Oncol 19 Suppl 2(-): ii27-8 (2008)
2001  
42
1997  
43
Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials.
[9093719] Ann Oncol 8(2): 117-36 (1997)
2008  
44
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.
[18041064] Cancer 112(2): 250-9 (2008)
2007  
45
Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.
[17279586] Cancer 109(5): 915-23 (2007)
2006  
46
Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy.
[17019735] Cancer 107(9): 2108-21 (2006)
2005  
47
Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.
[15981284] Cancer 104(4): 794-801 (2005)
2005  
48
Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.
[15744746] Cancer 103(7): 1408-14 (2005)
2003  
49
Fibrolamellar hepatocellular carcinoma in children and adolescents.
[12673731] Cancer 97(8): 2006-12 (2003)
2010  
50
Systemic therapy for advanced hepatocellular carcinoma: past, present, and future.
[20404795] Cancer Control 17(2): 120-9 (2010)
2010  
51
Stereotactic body radiation therapy for liver metastases and primary hepatocellular carcinoma: normal tissue tolerances and toxicity.
[20404794] Cancer Control 17(2): 111-9 (2010)
2010  
52
Nonsurgical options for hepatocellular carcinoma: evolving role of external beam radiotherapy.
[20404793] Cancer Control 17(2): 100-10 (2010)
2010  
53
Interventional radiological treatment of hepatocellular carcinoma.
[20404792] Cancer Control 17(2): 87-99 (2010)
2010  
54
Liver transplantation for hepatocellular carcinoma.
[20404791] Cancer Control 17(2): 83-6 (2010)
2010  
55
Imaging of the liver for hepatocellular cancer.
[20404790] Cancer Control 17(2): 72-82 (2010)
2008  
56
Transcatheter arterial chemoembolization and percutaneous ethanol injection for Hepatocellular carcinoma: a retrospective review of the Veterans Affairs Caribbean Healthcare System.
[18094664] Cancer Control 15(1): 80-5 (2008)
2009  
57
Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
[19574418] J Natl Cancer Inst 101(15): 1066-82 (2009)
2008  
58
Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma.
[18695130] J Natl Cancer Inst 100(16): 1121-3 (2008)
2009  
59
Sorafenib for the treatment of unresectable hepatocellular carcinoma.
[19144678] Oncologist 14(1): 95-100 (2009)
2008  
60
2007  
61
Presurgical chemotherapy in patients being considered for liver resection.
[17673614] Oncologist 12(7): 825-39 (2007)
1976  
62
Precursor lesions for liver cancer in humans.
[776394] Cancer Res 36(7 PT 2): 2579-83 (1976)
2004  
63
Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers.
[14656944] Carcinogenesis 25(4): 541-7 (2004)
1974  
64
Hepatoma--nature's model tumor. A review.
[4358463] Am J Pathol 74(1): 179-210 (1974)
2002  
65
Ablative therapy for liver tumours.
[11950826] Gut 50(5): 733-9 (2002)
2009  
66
The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review.
[19357024] Hepatobiliary Pancreat Dis Int 8(2): 124-33 (2009)
2008  
67
Hepatocellular carcinoma: current management and recent advances.
[18522878] Hepatobiliary Pancreat Dis Int 7(3): 237-57 (2008)
2007  
68
Specific molecular markers in hepatocellular carcinoma.
[17548245] Hepatobiliary Pancreat Dis Int 6(3): 241-7 (2007)
2006  
69
Local injection therapy for hepatocellular carcinoma.
[16481276] Hepatobiliary Pancreat Dis Int 5(1): 16-21 (2006)
2003  
70
Molecular therapy and prevention of hepatocellular carcinoma.
[14599923] Hepatobiliary Pancreat Dis Int 2(1): 11-22 (2003)
2008  
71
Molecular targeted therapies in hepatocellular carcinoma.
[18821591] Hepatology 48(4): 1312-27 (2008)
2000  
72
2009  
73
131-iodine Lipiodol therapy in hepatocellular carcinoma.
[19521315] Q J Nucl Med Mol Imaging 53(3): 348-55 (2009)
2009  
74
Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
[19521310] Q J Nucl Med Mol Imaging 53(3): 311-6 (2009)
2009  
75
Current management strategy of hepatocellular carcinoma.
[19598295] World J Gastroenterol 15(26): 3210-6 (2009)
2009  
76
Diagnosis of hepatocellular carcinoma.
[19294759] World J Gastroenterol 15(11): 1301-14 (2009)
2009  
77
2009  
78
Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis.
[19132775] World J Gastroenterol 15(2): 231-9 (2009)
2008  
79
Laser ablation of hepatocellular carcinoma--a review.
[19084930] World J Gastroenterol 14(47): 7170-4 (2008)
2008  
80
Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.
[18666317] World J Gastroenterol 14(27): 4300-8 (2008)
2008  
81
Cystic tumors of the liver: a practical approach.
[18595127] World J Gastroenterol 14(23): 3616-20 (2008)
2008  
82
Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma.
[18473401] World J Gastroenterol 14(18): 2797-801 (2008)
2008  
83
DNA methylation in hepatocellular carcinoma.
[18350605] World J Gastroenterol 14(11): 1741-8 (2008)
2008  
84
Current role of ultrasound for the management of hepatocellular carcinoma.
[18350602] World J Gastroenterol 14(11): 1710-9 (2008)
2008  
85
Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.
[18350600] World J Gastroenterol 14(11): 1690-8 (2008)
2008  
86
Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review.
[18350597] World J Gastroenterol 14(11): 1664-9 (2008)
2008  
87
Surgical treatment of hepatocellular carcinoma: evidence-based outcomes.
[18205256] World J Gastroenterol 14(5): 685-92 (2008)
2006  
88
Serum tumor markers for detection of hepatocellular carcinoma.
[16534867] World J Gastroenterol 12(8): 1175-81 (2006)
2005  
89
Hepatocellular carcinoma: therapy and prevention.
[16437707] World J Gastroenterol 11(47): 7391-400 (2005)
2002  
90
Radiofrequence ablation of liver cancers.
[12046057] World J Gastroenterol 8(3): 393-9 (2002)
2001  
91
Hepatocellular carcinoma--cause, treatment and metastasis.
[11819809] World J Gastroenterol 7(4): 445-54 (2001)
2008  
92
Molecular mechanisms of hepatocellular carcinoma.
[19003900] Hepatology 48(6): 2047-63 (2008)
2004  
93
AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings.
[15565604] Hepatology 40(6): 1465-73 (2004)
2003  
94
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.
[12540794] Hepatology 37(2): 429-42 (2003)
2004  
95
2004  
96
Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients.
[15326039] Br J Radiol 77(920): 633-40 (2004)
2006  
97
Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation.
[17056878] AJR Am J Roentgenol 187(5): W481-9 (2006)
2006  
98
Contrast-enhancing hepatic eosinophilic abscess during the hepatic arterial phase: a mimic of hepatocellular carcinoma.
[16357397] AJR Am J Roentgenol 186(1): 168-73 (2006)
2003  
99
Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies.
[14627588] AJR Am J Roentgenol 181(6): 1635-40 (2003)
2001  
100
Radiofrequency ablation of the liver: current status.
[11133529] AJR Am J Roentgenol 176(1): 3-16 (2001)
1997  
101
Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
[9393154] AJR Am J Roentgenol 169(6): 1507-15 (1997)
1992  
102
Differential diagnosis of hyperintense liver lesions on T1-weighted MR images.
[1329456] AJR Am J Roentgenol 159(5): 1017-20 (1992)
1990  
103
Liver tumor imaging: current concepts.
[2117343] AJR Am J Roentgenol 155(3): 473-84 (1990)
2008  
104
Exophytic benign and malignant hepatic tumors: CT imaging features.
[18253078] Korean J Radiol 9(1): 67-75 (2008)
2009  
105
MR imaging of hypervascular liver masses: a review of current techniques.
[19325055] Radiographics 29(2): 385-402 (2009)
2008  
106
Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features.
[18480482] Radiographics 28(3): 747-69 (2008)
2008  
107
Spectrum of CT findings after radiofrequency ablation of hepatic tumors.
[18349446] Radiographics 28(2): 379-90; discussion 390-2 (2008)
2008  
108
Recent advances in transarterial therapy of primary and secondary liver malignancies.
[18203933] Radiographics 28(1): 101-17 (2008)
2008  
109
Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.
[18203932] Radiographics 28(1): 81-99 (2008)
2005  
110
Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management.
[16227497] Radiographics 25 Suppl 1(-): S57-68 (2005)
2005  
111
Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.
[16227496] Radiographics 25 Suppl 1(-): S41-55 (2005)
2005  
112
Staging and current treatment of hepatocellular carcinoma.
[16227495] Radiographics 25 Suppl 1(-): S3-23 (2005)
2005  
113
Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging.
[16160113] Radiographics 25(5): 1299-320 (2005)
2005  
114
Fat-containing lesions of the liver: radiologic-pathologic correlation.
[15798052] Radiographics 25(2): 321-31 (2005)
2003  
115
Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings.
[12533646] Radiographics 23(1): 107-21 (2003)
2002  
116
Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein.
[12235337] Radiographics 22(5): 1077-91 (2002)
2002  
117
Transhepatic portal vein embolization: anatomy, indications, and technical considerations.
[12235336] Radiographics 22(5): 1063-76 (2002)
2002  
118
Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.
[12235331] Radiographics 22(5): 1023-36; discussion 1037-9 (2002)
2000  
119
Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.
[10682768] Radiographics 20(1): 9-27 (2000)
1999  
120
Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
[10194790] Radiographics 19(2): 453-71 (1999)
1999  
121
CT and MR imaging of benign hepatic and biliary tumors.
[10194789] Radiographics 19(2): 431-51 (1999)
1999  
122
Chemoembolization of hepatic neoplasms: safety, complications, and when to worry.
[10194787] Radiographics 19(2): 399-414 (1999)
1998  
123
The Rocky liver: radiologic-pathologic correlation of calcified hepatic masses.
[9599391] Radiographics 18(3): 675-85; quiz 726 (1998)
1994  
124
Primary liver neoplasms: MR imaging with pathologic correlation.
[8066263] Radiographics 14(3): 459-82 (1994)
1993  
125
From the archives of the AFIP. Infantile hemangioendothelioma of the liver revisited.
[8316672] Radiographics 13(3): 657-70 (1993)
1989  
126
The CT appearance of cystic masses of the liver.
[2538868] Radiographics 9(2): 307-22 (1989)
1988  
127
Undiversion of the urinary tract: the pre-and postoperative evaluation.
[3283866] Radiographics 8(2): 213-33 (1988)
1998  
128
Diagnostic imaging and interventional therapy of hepatocellular carcinoma.
[9828792] Br J Radiol 71(848): 808-18 (1998)
2007  
129
Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison.
[17356175] Radiology 243(2): 422-30 (2007)
2005  
130
Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: correlation between dynamic CT and density of tumor microvessels.
[16244261] Radiology 237(2): 529-34 (2005)
2002  
131
Angiographic classification of hepatic hemangiomas in infants.
[11867787] Radiology 222(3): 693-8 (2002)
2002  
132
Primary hepatic angiosarcoma: findings at CT and MR imaging.
[11867783] Radiology 222(3): 667-73 (2002)
1999  
133
Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases.
[10551212] Radiology 213(2): 352-61 (1999)
2009  
134
Significance of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
[20035286] Acta Med Okayama 63(6): 299-304 (2009)
2009  
135
An overview of hepatocellular carcinoma study by omics-based methods.
[19129945] Acta Biochim Biophys Sin (Shanghai) 41(1): 1-15 (2009)
2010  
136
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555104] Ann Oncol 21 Suppl 5(-): v59-64 (2010)
2009  
137
Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454459] Ann Oncol 20 Suppl 4(-): 41-5 (2009)
2010  
138
Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.
[20405327] Ann Surg Oncol 17(5): 1226-33 (2010)
2011  
139
Advanced hepatocellular carcinoma. Review of targeted molecular drugs.
[21301005] Ann Hepatol 10(1): 21-7 (2011)
2010  
140
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria.
[20373461] Liver Transpl 16(4): 503-12 (2010)
2010  
141
The Milan criteria: no room on the metro for the king?
[20209585] Liver Transpl 16(3): 252-5 (2010)
2004  
142
Liver transplantation in patients with hepatocellular carcinoma.
[14762845] Liver Transpl 10(2 Suppl 1): S81-5 (2004)
2004  
143
Percutaneous ablation of hepatocellular carcinoma: state-of-the-art.
[14762847] Liver Transpl 10(2 Suppl 1): S91-7 (2004)
2004  
144
Prevention and treatment of hepatocellular carcinoma.
[14762850] Liver Transpl 10(2 Suppl 1): S111-4 (2004)
2004  
145
The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
[14762851] Liver Transpl 10(2 Suppl 1): S115-20 (2004)
2004  
146
Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view.
[14762831] Liver Transpl 10(2 Suppl 1): S3-8 (2004)
2004  
147
Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience.
[14762832] Liver Transpl 10(2 Suppl 1): S9-15 (2004)
2004  
148
The current status of imaging diagnosis of hepatocellular carcinoma.
[14762834] Liver Transpl 10(2 Suppl 1): S20-5 (2004)
2004  
149
Fine needle biopsy of focal liver lesions: the hepatologist's point of view.
[14762835] Liver Transpl 10(2 Suppl 1): S26-9 (2004)
2004  
150
Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome.
[14762838] Liver Transpl 10(2 Suppl 1): S39-45 (2004)
2004  
151
The surgical approach to HCC: our progress and results in Japan.
[14762839] Liver Transpl 10(2 Suppl 1): S46-52 (2004)
2004  
152
Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview.
[14762841] Liver Transpl 10(2 Suppl 1): S58-63 (2004)
2004  
153
Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations.
[14762844] Liver Transpl 10(2 Suppl 1): S74-80 (2004)
2008  
154
Liver tumors: pediatric population.
[18975283] Liver Transpl 14(11): 1545-56 (2008)
2007  
155
Clinical and molecular classification of hepatocellular carcinoma.
[17969094] Liver Transpl 13(11 Suppl 2): S13-6 (2007)
2011  
156
P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis.
[21799651] World J Gastroenterol 17(25): 3043-8 (2011)
2011  
157
Contrast-enhanced multiple-phase imaging features in hepatic epithelioid hemangioendothelioma.
[21941423] World J Gastroenterol 17(30): 3544-53 (2011)
2011  
158
Surgicopathological classification of hepatic space-occupying lesions: a single-center experience with literature review.
[21633636] World J Gastroenterol 17(19): 2372-8 (2011)
2011  
159
Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.
[21472097] World J Gastroenterol 17(11): 1400-9 (2011)
2011  
160
Therapeutic options for intermediate-advanced hepatocellular carcinoma.
[21483627] World J Gastroenterol 17(13): 1685-9 (2011)
2010  
161
Undifferentiated liver embryonal sarcoma in adults: a report of four cases and literature review.
[20872975] World J Gastroenterol 16(37): 4725-32 (2010)
2010  
162
Clinical features of hepatitis B virus-related hepatocellular carcinoma.
[20503445] World J Gastroenterol 16(20): 2463-7 (2010)
2010  
163
Present and future possibilities for early diagnosis of hepatocellular carcinoma.
[20101765] World J Gastroenterol 16(4): 418-24 (2010)
2010  
164
Surgical treatment for liver cancer.
[20180230] World J Gastroenterol 16(8): 927-33 (2010)
2007  
165
Genotype phenotype classification of hepatocellular adenoma.
[17569132] World J Gastroenterol 13(19): 2649-54 (2007)
2007  
166
Perivascular epithelioid cell tumor of the liver: a report of two cases and review of the literature.
[17907305] World J Gastroenterol 13(41): 5537-9 (2007)
2007  
167
Genetics of hepatocellular carcinoma.
[17511024] World J Gastroenterol 13(16): 2271-82 (2007)
2009  
168
Liver transplantation for hepatocellular carcinoma.
[19938188] World J Gastroenterol 15(44): 5511-6 (2009)
2003  
169
Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases.
[12819340] Radiology 228(2): 465-72 (2003)
2005  
170
Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
[15858105] Radiology 235(2): 659-67 (2005)
2008  
171
MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
[18430871] Radiology 247(2): 311-30 (2008)
2008  
172
Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.
[18605975] Biochemistry (Mosc) 73(5): 504-13 (2008)
2009  
173
Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature.
[19637355] Cancer 115(21): 4895-906 (2009)
2011  
174
Benign liver masses and lesions in children: 53 cases over 12 years.
[21991714] Isr Med Assoc J 13(9): 542-7 (2011)
2010  
175
Sorafenib for the treatment of advanced hepatocellular carcinoma.
[20507799] Health Technol Assess 14 Suppl 1(-): 17-21 (2010)
2010  
176
Focal nodular hyperplasia, hepatocellular adenomas: past, present, future.
[20537479] Gastroenterol Clin Biol 34(6-7): 355-8 (2010)
2006  
177
Hepatocellular carcinoma (primary cancer of the liver).
[17151564] Gastroenterol Clin Biol 30 Spec No 2(-): 2S57-2S61 (2006)
2009  
178
Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation.
[19398289] Gastroenterol Clin Biol 33(5): 361-9 (2009)
2011  
179
Treatment options in hepatocellular carcinoma today.
[21482502] Scand J Surg 100(1): 22-9 (2011)
2007  
180
Distinguishing benign from malignant liver tumours.
[17921080] Cancer Imaging 7 Spec No A(-): S1-14 (2007)
2007  
181
Post-treatment imaging of liver tumours.
[17921098] Cancer Imaging 7 Spec No A(-): S28-36 (2007)
2006  
182
Current staging of hepatocellular carcinoma: imaging implications.
[16829469] Cancer Imaging 6(-): 83-94 (2006)
2008  
183
Thermal ablation of hepatocellular carcinoma.
[18331969] Cancer Imaging 8(-): 19-26 (2008)
2004  
184
2011  
185
Usefulness of contrast enhanced ultrasound guidance in percutaneous biopsies of liver tumors.
[21725517] J Gastrointestin Liver Dis 20(2): 191-6 (2011)
2010  
186
Solitary fibrous liver tumor: is surgical approach the best option?
[20361081] J Gastrointestin Liver Dis 19(1): 81-4 (2010)
2008  
187
Vascular changes in hepatocellular carcinoma.
[18484619] Anat Rec (Hoboken) 291(6): 721-34 (2008)
2010  
188
Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.
[21180590] Therap Adv Gastroenterol 3(1): 55-66 (2010)
2009  
189
Surgery for malignant liver tumors.
[19841555] J Cancer Res Ther 5(3): 154-60 (2009)
2010  
190
The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis.
[21173943] Med Ultrason 12(2): 145-9 (2010)
2011  
191
Contrast enhanced ultrasound for the diagnosis of liver hemangiomas in clinical practice.
[21655534] Med Ultrason 13(2): 95-101 (2011)
2011  
192
Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
[21655536] Med Ultrason 13(2): 108-13 (2011)
2011  
193
Targeting insulin-like growth factor axis in hepatocellular carcinoma.
[21729319] J Hematol Oncol 4(-): 30 (2011)
2006  
194
Efficiency of MR imaging in the detection of malignant liver lesions.
[16538579] Diagn Interv Radiol 12(1): 17-21 (2006)
2007  
195
2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group.
[17186233] Pediatr Radiol 37(2): 123-32; quiz 249-50 (2007)
2010  
196
Radiofrequency ablation of liver tumors (I): biological background.
[20234157] Medicina (Kaunas) 46(1): 13-7 (2010)
2010  
197
Radiofrequency ablation of liver tumors (II): clinical application and outcomes.
[20440080] Medicina (Kaunas) 46(2): 81-8 (2010)
2002  
198
Molecular aspects of hepatic carcinogenesis.
[11896411] Rev Inst Med Trop Sao Paulo 44(1): 39-48 (2002)
2010  
199
Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option?
[20887322] HPB (Oxford) 12(8): 546-53 (2010)
2008  
200
Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver.
[19088924] HPB (Oxford) 10(6): 396-404 (2008)
2011  
201
Inflammatory pseudo-tumor of the liver: a rare pathological entity.
[21255461] World J Surg Oncol 9(-): 5 (2011)
2011  
202
Solitary fibrous tumor of the liver: a case report.
[21443810] World J Surg Oncol 9(-): 37 (2011)
2008  
203
Primary carcinoid tumors of the liver.
[18727836] World J Surg Oncol 6(-): 91 (2008)
2011  
204
Liver cancer: Targeted future options.
[21423913] World J Hepatol 3(2): 38-44 (2011)
2011  
205
Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future.
[21307982] World J Hepatol 3(1): 8-14 (2011)
2009  
206
Inflammatory myofibroblastic tumor of the liver: a case report.
[19530046] Turk J Gastroenterol 20(2): 129-34 (2009)
2011  
207
Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.
[21942912] BioDrugs 25(5): 275-84 (2011)
2011  
208
Clinical features of infantile hepatic hemangioendothelioma.
[21949521] Korean J Pediatr 54(6): 260-6 (2011)
2008  
209
Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.
[18830105] J Comput Assist Tomogr 32(5): 750-6 (2008)
2008  
210
Liver stem cells and tgf-Beta in hepatic carcinogenesis.
[19343145] Gastrointest Cancer Res 2(4 Suppl): S27-30 (2008)
2011  
211
Primary glomus tumor of the liver: a rare case report and review of the literature.
[21934228] Indian J Pathol Microbiol 54(3): 584-7 (2011)
2011  
212
Primary hepatic gastrinoma: Report of a case and review of literature.
[21607163] World J Gastrointest Pathophysiol 2(2): 26-30 (2011)
2010  
213
Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system.
[21191096] Toxicol Pathol 38(7 Suppl): 5S-81S (2010)
2010  
214
Spontaneous rupture of hepatic hemangiomas: A review of the literature.
[21191518] World J Hepatol 2(12): 428-33 (2010)
PMC   
215
Fiducial placement for stereotactic body radiation therapy under only endoscopic ultrasonography guidance in pancreatic and hepatic malignancy: practical feasibility and safety.
[24516706] Gut Liver 8(1):88-93 (2014)
PMC   
216
Clinical features, image findings, and prognosis of inflammatory pseudotumor of the liver: a multicenter experience of 45 cases.
[24516702] Gut Liver 8(1):58-63 (2014)
PMC   
217
Changes in the management of benign liver tumours: an analysis of 285 patients.
[23297727] HPB (Oxford) 15(2):156-63 (2013)
PMC   
218
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.
[24574801] World J Gastroenterol 20(5):1268-88 (2014)
PMC   
219
Treatment of metastatic liver tumors using stereotactic ablative radiotherapy.
[24578789] World J Radiol 6(2):18-25 (2014)
PMC   
220
Management of hepatocellular adenoma: comparison of resection, embolization and observation.
[23374365] HPB (Oxford) 15(3):235-43 (2013)
PMC   
221
Microwave ablation of hepatic malignancy.
[24436518] Semin Intervent Radiol 30(1):56-66 (2013)
PMC   
222
Radiofrequency ablation of liver tumors.
[24436517] Semin Intervent Radiol 30(1):49-55 (2013)
PMC   
223
Transhepatic therapies for metastatic uveal melanoma.
[24436516] Semin Intervent Radiol 30(1):39-48 (2013)
PMC   
224
Successful management of multi-focal hepatic infantile hemangioendothelioma using TACE/surgery followed by maintenance metronomic therapy.
[22605610] BMJ Case Rep 2012(): (2012)
PMC   
225
Nested stromal-epithelial tumour of the liver: An unusual liver entity.
[24672646] World J Hepatol 6(3):155-9 (2014)
PMC   
226
Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors.
[24672640] World J Hepatol 6(3):107-13 (2014)
PMC   
227
Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features.
[23640129] Mod Pathol 26(12):1586-93 (2013)
PMC   
228
Multi-slice computed tomography manifestations of hepatic epithelioid angiomyolipoma.
[2469666] World J Gastroenterol 20(12):3364-8 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Neoplasia).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Neoplasia).php on line 92